DS
SRTS icon

David Shaw’s Sensus Healthcare SRTS Stock Holding History

David Shaw’s Portfolio SRTS Stock Details SRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,535
Closed -$40K – 4825
2024
Q1 		$40K Sell
10,535
-52,221
-83% -$189K ﹤0.01% 4080
2023
Q4 		$148K Sell
62,756
-13,038
-17% -$30.5K ﹤0.01% 3927
2023
Q3 		$210K Sell
75,794
-16,982
-18% -$51.9K ﹤0.01% 3743
2023
Q2 		$292K Sell
92,776
-19
-0% -$69 ﹤0.01% 3603
2023
Q1 		$483K Buy
92,795
+11,823
+15% +$84.9K ﹤0.01% 3571
2022
Q4 		$601K Buy
80,972
+55,822
+222% +$504K ﹤0.01% 3756
2022
Q3 		$315K Buy
25,150
+5,555
+28% +$66.4K ﹤0.01% 4275
2022
Q2 		$150K Buy
+19,595
New +$164K ﹤0.01% 4641

Other funds holding SRTS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $1.12B AUM 390.6% 1-Year Est. Return

David Shaw's SRTS Position: Q2 2024 in Review

David Shaw sold out of Sensus Healthcare (SRTS) in Q2 2024, closing a stake of 10,535 shares — an estimated $40K sold.

David Shaw first reported a position in SRTS in Q2 2022 and held it in 8 quarters. The position peaked at $601K in Q4 2022. 47 funds tracked by Wall St. Rank hold SRTS as of Q2 2024.

  • David Shaw reported no remaining Sensus Healthcare position as of Q2 2024 after selling out during the quarter.
  • David Shaw sold 10,535 Sensus Healthcare shares in Q2 2024, an estimated $40K.
  • David Shaw first reported a position in Sensus Healthcare in Q2 2022 and held it in 8 quarters.
  • David Shaw's Sensus Healthcare position peaked at $601K in Q4 2022.
  • 47 funds tracked by Wall St. Rank held Sensus Healthcare as of Q2 2024.

Based on D.E. Shaw & Co's 13F filing for Q2 2024, filed 14 Aug 2024.